Applications of fluorescence in situ hybridization in cytopathology: A review

Acta Cytologica

Volumn 49, Issue 6, 2005, Pages 587-594

  Oliveira, Andre M ^a   French, Christopher A ^b  

^a MAYO CLINIC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

FISH; Hybridization, fluorescence in situ; Molecular genetics

Indexed keywords

DNA; RNA; SATELLITE DNA;

CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9P; CYTOGENETICS; CYTOPATHOLOGY; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE REARRANGEMENT; GENE TARGETING; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTEMATIC REVIEW; TUMOR DIAGNOSIS;

EID: 27944502455     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326244     Document Type: Review

References (68)

1. Miller OJ: The fifties and the renaissance in human and mammalian cytogenetics. Genetics 1995;139:489-494
2. Karakousis CP, Dal Cin P, Turc-Carel C, Limon J, Sandberg AA: Chromosomal changes in soft-tissue sarcomas: A new diagnostic parameter. Arch Surg 1987;122:1257-1260
3. Trent JM: Clinical correlations of chromosome change in human solid tumors: The tip of the iceberg? J Natl Cancer Inst 1989;81:1852-1853
4. Rabbitts TH: Chromosomal translocations in human cancer. Nature 1994;372:143-149
5. Sandberg AA, Turc-Carel C, Gemmill RM: Chromosomes in solid tumors and beyond. Cancer Res 1988;48:1049-1059
6. Pardue ML, Gall JG: Chromosomal localization of mouse satellite DNA. Science 1970;168:1356-1358
7. Vorsanova SG, Yurov YB, Alexandrov IA, Demidova IA, Mitkevich SP, Tirskaia AF: 18p-Syndrome: An unusual case and diagnosis by in situ hybridization with chromosome 18-specific alphoid DNA sequence. Hum Genet 1986;72:185-187
8. Xiao S, Renshaw A, Cibas ES, Hudson TJ, Fletcher JA: Novel fluorescence in situ hybridization approaches in solid tumors: Characterization of frozen specimens, touch preparations, and cytological preparations. Am J Pathol 1995;147:896-904
9. Taylor CP, Bown NP, McGuckin AG, Lunec J, Malcolm AJ, Pearson AD, Sheer D: Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. United Kingdom Children's Cancer Study Group. Br J Cancer 2000;83:40-49
10. Abati A, Sanford JS, Fetsch P, Marincola FM, Wolman SR: Fluorescence in situ hybridization (FISH): A user's guide to optimal preparation of cytologic specimens. Diagn Cytopathol 1995;13:486-492
11. Bull JH, Harnden P: Efficient nuclear FISH on paraffin-embedded tissue sections using microwave pretreatment. Biotechniques 1999;26:416-422
12. Sambrook J, Fritsch E, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press, 1989
13. Fletcher JA: DNA in situ-hybridization as an adjunct in tumor diagnosis. Am J Clin Pathol 1999;112:S11-S18
14. Wilkinson D: In Situ Hybridization: A Practical Approach. Oxford, IRL Press, 1998
15. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13
16. Lichter P, Ward DC: Is non-isotopic in situ hybridization finally coming of age? Nature 1990;345:93-94
17. Lee W, Han K, Drut RM, Harris CP, Meisner LF: Use of fluorescence in situ hybridization for retrospective detection of aneuploidy in multiple myeloma. Genes Chromosomes Cancer 1993;7:137-143
18. Mian C, Bancher D, Kohlberger P, Kainz C, Haitel A, Czerwenka K, Stani J, Breitenecker G, Wiener H: Fluorescence in situ hybridization in cervical smears: Detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection. Gynecol Oncol 1999;75:41-46
19. Huegel A, Coyle L, McNeil R, Smith A: Evaluation of interphase fluorescence in situ hybridization on direct hematological bone marrow smears. Pathology 1995;27:86-90
20. French CA: Fluorescence in situ hybridization in destained archival preparations. Unpublished manuscript, 2003
21. Sheldon S: Fluorescent in situ hybridization. In Morphology Methods. Edited by RV Lloyd. Totowa, Humana Press, 2001
22. Lee C, Wevrick R, Fisher RB, Ferguson-Smith MA, Lin CC: Human centromeric DNAs. Hum Genet 1997;100:291-304
23. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85: 6622-6626
24. Burke DT, Carle GF, Olson MV: Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. Science 1987;236:806-812
25. Shizuya H, Birren B, Kim UJ, Mancino V, Slepak T, Tachiiri Y, Simon M: Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc Natl Acad Sci USA 1992;89:8794-8797
26. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature 1997;386:623-627
27. Dewald GW, Noel P, Dahl RJ, Spurbeck JL: Chromosome abnormalities in malignant hematologic disorders. Mayo Clin Proc 1985;60:675-689
28. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Cuneo A, Knuutila S, Elonen E, Gahrton G: Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990;323:720-724
29. Knuutila S, Elonen E, Teerenhovi L, Rossi L, Leskinen R, Bloomfield CD, de la Chapelle A: Trisomy 12 in B cells of patients with B-cell chronic lymphocytic leukemia. N Engl J Med 1986;314:865-869
30. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P: Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-1916
31. Dei Tos AP, Dal Cin P: The role of cytogenetics in the classicication of soft tissue tumours. Virchows Arch 1997;431:83-94
32. Skacel M, Pettay JD, Tsiftsakis EK, Procop GW, Biscotti CV, Tubbs RR: Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides. Anal Quant Cytol Histol 2001;23:381-387
33. Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS, Procop GW, Jones JS, Ulchaker J, Zippe CD, Tubbs RR: Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 2003; 169:2101-2105
34. Veeramachaneni R, Nordberg ML, Shi R, Herrera GA, Turbat-Herrera EA: Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol 2003;28:301-307
35. Pane F, Intrieri M, Quintarelli C, Izzo B, Muccioli GC, Salvatore F: BCR/ABL genes and leukemic phenotype: From molecular mechanisms to clinical correlations. Oncogene 2002;21: 8652-8667
36. Melo JV: The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996;88:2375-2384
37. Sinclair PB, Green AR, Grace C, Nacheva EP: Improved sensitivity of BCR-ABL detection: A triple-probe three-color fluorescence in situ hybridization system. Blood 1997;90:1395-1402
38. Dewald GW: Interphase FISH studies of chronic myeloid leukemia. Methods Mol Biol 2002;204:311-342
39. Desmaze C, Brizard F, Turc-Carel C, Melot T, Delattre O, Thomas G, Aurias A: Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors. Cancer Genet Cytogenet 1997;97:12-19
40. Janz M, De Leeuw B, Weghuis DO, Werner M, Nolte M, Geurts Van Kessel A, Nordheim A, Hipskind RA: Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma. J Pathol 1995;175:391-396
41. Remstein ED, Kurtin PJ, Buno I, Bailey RJ, Proffitt J, Wyatt WA, Hanson CA, Dewald GW: Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br J Haematol 2000;110:856-862
42. Boxer LM, Dang CV: Translocations involving c-myc and c-myc function. Oncogene 2001;20:5595-5610
43. Schwab M: Oncogene amplification in solid tumors. Semin Cancer Biol 1999;9:319-325
44. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J: Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983;305:245-248
45. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM: Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 1983;80:1707-1711
46. Moore JG, To V, Patel SJ, Sneige N: HER-2/neu gene amplification in breast imprint cytology analyzed by fluorescence in situ hybridization: Direct comparison with companion tissue sections. Diagn Cytopathol 2000;23:299-302
47. Bozzetti C, Nizzoli R, Guazzi A, Flora M, Bassano C, Crafa P, Naldi N, Cascinu S: HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer. Ann Oncol 2002;13:1398-1403
48. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N: Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 1999;340:1954-1961
49. Mehes G, Luegmayr A, Kornmuller R, Ambros IM, Ladenstein R, Gadner H, Ambros PF: Detection of disseminated tumor cells in neuroblastoma: 3 Log improvement in sensitivity by automatic immunofluorescence plus FISH (AIPF) analysis compared with classical bone marrow cytology. Am J Pathol 2003; 163:393-399
50. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallic BL, Murphree AL, Strong LC, White RL: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305:779-784
51. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994;266:1821-1828
52. Klein G, Klein E: Evolution of tumours and the impact of molecular oncology. Nature 1985;315:190-195
53. Murphree AL, Benedict WF: Retinoblastoma: Clues to human oncogenesis. Science 1984;223:1028-1033
54. Lasko D, Cavenee W, Nordenskjold M: Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 1991;25: 281-314
55. Granados R, Cibas ES, Fletcher JA: Cytogenetic analysis of effusions from malignant mesothelioma: A diagnostic adjunct to cytology. Acta Cytol 1994;38:711-717
56. Sainati L, Spinelli M, Leszl A, Cocito MG, Stella M, Basso G: Combined cell sorting and FISH for detection of minimal residual disease in bone marrow of children with acute leukemia or solid tumors. Eur J Histochem (suppl 2) 1997;41:167-168
57. Eckschlager T, McClain K: Comparison of fluorescent in situ hybridization (FISH) and the polymerase chain reaction (PCR) for detection of residual neuroblastoma cells. Neoplasma 1996;43:301-303
58. Raimondi SC: Fluorescence in situ hybridization: Molecular probes for diagnosis of pediatric neoplastic diseases. Cancer Invest 2000;18:135-147
59. Wu CJ, Neuberg D, Chillemi A, McLaughlin S, Hochberg EP, Galinsky I, DeAngelo D, Soiffer RJ, Alyea EP, Capdeville R, Stone RM, Ritz J: Quantitative monitoring of BCR/ABL transcript during STI-571 therapy. Leuk Lymphoma 2002;43: 2281-2289
60. Hsi BL, Xiao S, Fletcher JA: Chromogenic in situ hybridization and FISH in pathology. In Molecular Cytogenetics: Protocols and Applications. Edited by YS Fan. Totowa, Humana Press, 1998
61. Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J: Chromogenic in situ hybridization: A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol 2000;157:1467-1472
62. Speel EJ, Ramaekers FC, Hopman AH: Cytochemical detection systems for in situ hybridization, and the combination with immunocytochemistry, 'who is still afraid of red, green and blue?' Histochem J 1995;27:833-858
63. Hopman AH, Claessen S, Speel EJ: Multi-colour brightfield in situ hybridisation on tissue sections. Histochem Cell Biol 1997;108:291-298
64. Dave BJ, Nelson M, Pickering DL, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Sanger WG: Cytogenetic characterization of diffuse large cell lymphoma using multicolor fluorescence in situ hybridization. Cancer Genet Cytogenet 2002;132:125-132
65. Nacheva EP, Gribble S, Andrews K, Wienberg J, Grace CD: Screening for specific chromosome involvement in hematological malignancies using a set of seven chromosome painting probes: An alternative approach for chromosome analysis using standard FISH instrumentation. Cancer Genet Cytogenet 2000;122:65-72
66. Jalal SM, Law ME: Multicolor FISH. Methods Mol Biol 2002; 204:105-120
67. Gutierrez NC, Camps J, Hernandez JM, Garcia JL, Prat E, Gonzalez MB, Miro R, San Miguel JF: Multicolor fluorescence in situ hybridization studies in multiple myeloma and monoclonal gammopathy of undetermined significance. Hematol J 2003;4:67-70
68. Martin-Subero JI, Gesk S, Harder L, Grote W, Siebert R: Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification. Anticancer Res 2003;23:1139-1148